Global Auto Disable Syringes Market Insights, Trends & Future Development Status Recorded during 2018-2028
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
(EMAILWIRE.COM, November 17, 2018 ) Auto disable syringes are single use syringe designed to block the barrel from depressing again or break the plunger after a single use. These are a type of safety syringes intended to avoid reuse of syringes. Advanced auto disable syringes have additional features such as needle stick prevention involving a sheath or hood which slides over the needle after single use. Another mechanism involves either manual or spring loaded retraction of the needle into the barrel of the syringe after single use.
Request Customized Report As Per Your Requirements: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1053
Auto disable syringes Market: Drivers and Restraints
Risk of infection and transmission of deadly ailments such as blood borne diseases, HIV, viral hepatitis and others is the prime driver of the global Auto disable syringes Market. According to Centers for Disease Control and Prevention estimates approximately 1 in 10 new HIV diagnoses in the United States is attributed to drug use by injection. HIV can survive in an infected needle for up to 42 days, depending on conditions such as temperature humidity and others. The Centers for Disease Control and Prevention attributes the direct cost of needle stick injuries between $539 and $672 million per year, which signifies the presence of a large unmet need for auto disable syringes.
The drawbacks of traditional glass syringes include chances of improper disinfection, and human errors. Disposable plastic body syringes can transfer diseases due to improper disposal. These drawbacks are driving a faster market adoption for auto disable syringes.
Regulatory drivers of the global auto disable syringes market include the support provided by governments and judiciary exemplified by the Needlestick Safety and Prevention Act, and the needle and syringe exchanges programs. Sixteen US states passed laws authorizing needle and syringe exchanges including California through nonprescription sale.
The restraints on the global auto disable syringes market are the presence of monopolistic actions of the major needle manufacturers and hospital purchasing departments. Lack of legislation concerning auto disable syringes especially in poor regions of Asia Pacific and Middle East and Africa may hamper the global auto disable syringes market.
Auto disable syringes Market: Segmentation
To gain an accurate assessment of the global auto disable syringes market, the report is segmented based on mechanism, clinical indications, end users, and region.
Based on mechanism, the global auto disable syringes market is divided into the following:
Retractable
Non- Retractable
Others
Based on clinical indications, the global auto disable syringes market is segmented as below:
Vaccines
Infectious diseases
Inflammatory/Auto-Immune Diseases
Others
Based on end users, the global auto disable syringes market is segmented as below:
Hospitals and clinics
Ambulatory centers
Others
Auto disable syringes Market: Overview
The global market for auto disable syringes is consolidated with a few large players dominating the scene. The global auto disable syringes market trends include a definite shift in favor of developing regions of Asia Pacific, such as India, and China. There is also a strong trend of collaboration between large hospitals and service providers to benefit from infrastructure and skill training. Data sharing between players is another trend so as to reduce cost.
Some of the established vendors operating in the global auto disable syringes are NIPRO Medical Corporation, Becton, Dickinson and Company, JMI Syringes & Medical Devices Limited, Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc. Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation, and others.
For more information on this report, Please Visit: https://www.factmr.com/report/1053/auto-disable-syringes-market
Auto Disable Syringes Market: Key Players
Some of the major players in the global auto disable syringes market are NIPRO Medical Corporation, Becton, Dickinson and Company, JMI Syringes & Medical Devices Limited, Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc., Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation, and others. Collaboration between players and healthcare organizations is the most attractive strategy which can yield a premium and bulk sales. Thus, partnership with large hospitals and players is a neglected strategy which can yield dividends owing to faster adoption and lower cost.
The global auto disable syringes report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
Middle East and Africa
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Place an Inquire before purchase "Report": https://www.factmr.com/connectus/sample?flag=AE&rep_id=1053
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
Request Customized Report As Per Your Requirements: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1053
Auto disable syringes Market: Drivers and Restraints
Risk of infection and transmission of deadly ailments such as blood borne diseases, HIV, viral hepatitis and others is the prime driver of the global Auto disable syringes Market. According to Centers for Disease Control and Prevention estimates approximately 1 in 10 new HIV diagnoses in the United States is attributed to drug use by injection. HIV can survive in an infected needle for up to 42 days, depending on conditions such as temperature humidity and others. The Centers for Disease Control and Prevention attributes the direct cost of needle stick injuries between $539 and $672 million per year, which signifies the presence of a large unmet need for auto disable syringes.
The drawbacks of traditional glass syringes include chances of improper disinfection, and human errors. Disposable plastic body syringes can transfer diseases due to improper disposal. These drawbacks are driving a faster market adoption for auto disable syringes.
Regulatory drivers of the global auto disable syringes market include the support provided by governments and judiciary exemplified by the Needlestick Safety and Prevention Act, and the needle and syringe exchanges programs. Sixteen US states passed laws authorizing needle and syringe exchanges including California through nonprescription sale.
The restraints on the global auto disable syringes market are the presence of monopolistic actions of the major needle manufacturers and hospital purchasing departments. Lack of legislation concerning auto disable syringes especially in poor regions of Asia Pacific and Middle East and Africa may hamper the global auto disable syringes market.
Auto disable syringes Market: Segmentation
To gain an accurate assessment of the global auto disable syringes market, the report is segmented based on mechanism, clinical indications, end users, and region.
Based on mechanism, the global auto disable syringes market is divided into the following:
Retractable
Non- Retractable
Others
Based on clinical indications, the global auto disable syringes market is segmented as below:
Vaccines
Infectious diseases
Inflammatory/Auto-Immune Diseases
Others
Based on end users, the global auto disable syringes market is segmented as below:
Hospitals and clinics
Ambulatory centers
Others
Auto disable syringes Market: Overview
The global market for auto disable syringes is consolidated with a few large players dominating the scene. The global auto disable syringes market trends include a definite shift in favor of developing regions of Asia Pacific, such as India, and China. There is also a strong trend of collaboration between large hospitals and service providers to benefit from infrastructure and skill training. Data sharing between players is another trend so as to reduce cost.
Some of the established vendors operating in the global auto disable syringes are NIPRO Medical Corporation, Becton, Dickinson and Company, JMI Syringes & Medical Devices Limited, Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc. Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation, and others.
For more information on this report, Please Visit: https://www.factmr.com/report/1053/auto-disable-syringes-market
Auto Disable Syringes Market: Key Players
Some of the major players in the global auto disable syringes market are NIPRO Medical Corporation, Becton, Dickinson and Company, JMI Syringes & Medical Devices Limited, Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc., Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation, and others. Collaboration between players and healthcare organizations is the most attractive strategy which can yield a premium and bulk sales. Thus, partnership with large hospitals and players is a neglected strategy which can yield dividends owing to faster adoption and lower cost.
The global auto disable syringes report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
Middle East and Africa
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Place an Inquire before purchase "Report": https://www.factmr.com/connectus/sample?flag=AE&rep_id=1053
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/
Contact Information:
Fact.MR
James Hilton
Tel: +353-1-6111-593
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Fact.MR
James Hilton
Tel: +353-1-6111-593
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results